{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:43:43Z","timestamp":1769273023846,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.iac.2022.04.002","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T08:16:31Z","timestamp":1656576991000},"page":"591-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Asthma-Chronic Obstructive Pulmonary Disease Overlap"],"prefix":"10.1016","volume":"42","author":[{"given":"Kasey M.","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2022.04.002_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40413-018-0207-2","article-title":"Confounders of severe asthma: diagnoses to consider when asthma symptoms persist despite optimal therapy","volume":"11","author":"Gherasim","year":"2018","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.iac.2022.04.002_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/HCR.0000000000000271","article-title":"Phenotypes and characterization of COPD: a pulmonary rehabilitation perspective","volume":"38","author":"Raskin","year":"2018","journal-title":"J\u00a0Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.iac.2022.04.002_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/1753466618805662","article-title":"Asthma-COPD overlap: identification and optimal treatment","volume":"12","author":"Cosio","year":"2018","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.iac.2022.04.002_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5152\/TurkThoracJ.2018.18055","article-title":"The Prevalence of Asthma-COPD Overlap (ACO) Among Patients with Asthma","volume":"20","author":"Sevimli","year":"2019","journal-title":"Turk Thorac J"},{"key":"10.1016\/j.iac.2022.04.002_bib5","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jaci.2018.11.032","article-title":"Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO","volume":"143","author":"Hanania","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2022.04.002_bib6","doi-asserted-by":"crossref","first-page":"1700506","DOI":"10.1183\/13993003.00506-2017","article-title":"Diagnosis of asthma-COPD overlap: the five commandments","volume":"49","author":"Miravitlles","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2022.04.002_bib7","doi-asserted-by":"crossref","first-page":"j3772","DOI":"10.1136\/bmj.j3772","article-title":"Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets","volume":"358","author":"Leung","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.iac.2022.04.002_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.alit.2018.01.002","article-title":"Definition and diagnosis of asthma-COPD overlap (ACO)","volume":"67","author":"Yanagisawa","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.iac.2022.04.002_bib9","doi-asserted-by":"crossref","first-page":"190185","DOI":"10.1183\/16000617.0185-2019","article-title":"Asthma-COPD overlap: current understanding and the utility of experimental models","volume":"30","author":"Tu","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.iac.2022.04.002_bib10","doi-asserted-by":"crossref","first-page":"1700336","DOI":"10.1183\/13993003.00336-2017","article-title":"\"To define is to limit\": perspectives on asthma-COPD overlap syndrome and personalised medicine","volume":"49","author":"McDonald","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2022.04.002_bib11","doi-asserted-by":"crossref","first-page":"1700068","DOI":"10.1183\/13993003.00068-2017","article-title":"Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines","volume":"49","author":"Miravitlles","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2022.04.002_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5507\/bp.2013.039","article-title":"Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care","volume":"157","author":"Koblizek","year":"2013","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.iac.2022.04.002_bib13","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJMra1411863","article-title":"The Asthma-COPD Overlap Syndrome","volume":"373","author":"Postma","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2022.04.002_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11882-014-0509-6","article-title":"The asthma COPD overlap syndrome (ACOS)","volume":"15","author":"Bujarski","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.iac.2022.04.002_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/MCP.0000000000000118","article-title":"The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges","volume":"21","author":"Barrecheguren","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.iac.2022.04.002_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1183\/09031936.00008615","article-title":"Asthma, COPD and overlap syndrome: a longitudinal study in young European adults","volume":"46","author":"de Marco","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2022.04.002_bib17","doi-asserted-by":"crossref","first-page":"101021","DOI":"10.1016\/j.mam.2021.101021","article-title":"Asthma COPD overlap: Insights into cellular and molecular mechanisms","volume":"85","author":"Morissette","year":"2021","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.iac.2022.04.002_bib18","doi-asserted-by":"crossref","first-page":"4652898","DOI":"10.1155\/2020\/4652898","article-title":"Relationship of Serum Levels of IL-17, IL-18, TNF-alpha, and Lung Function Parameters in Patients with COPD, Asthma-COPD Overlap, and Bronchial Asthma","volume":"2020","author":"Kubysheva","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.iac.2022.04.002_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2022.04.002_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2147\/COPD.S153694","article-title":"Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach","volume":"13","author":"de Llano","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.iac.2022.04.002_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.alit.2018.01.001","article-title":"Asthma and COPD overlap pathophysiology of ACO","volume":"67","author":"Hikichi","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.iac.2022.04.002_bib22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1172\/JCI134333","article-title":"At last - linking ORMDL3 polymorphisms, decreased sphingolipid synthesis, and asthma susceptibility","volume":"130","author":"Wills-Karp","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.iac.2022.04.002_bib23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jaci.2019.07.023","article-title":"ORMDL3 and allergic asthma: From physiology to pathology","volume":"144","author":"James","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2022.04.002_bib24","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/rccm.201408-1458OC","article-title":"Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease","volume":"191","author":"Christenson","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.iac.2022.04.002_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jaip.2018.06.029","article-title":"Chronic rhinitis is a high-risk comorbidity for 30-day hospital readmission of patients with asthma and chronic obstructive pulmonary disease","volume":"7","author":"Singh","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2022.04.002_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archinternmed.2008.550","article-title":"Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis","volume":"169","author":"Singh","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.iac.2022.04.002_bib27","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.2147\/COPD.S114964","article-title":"Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome","volume":"11","author":"Lee","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.iac.2022.04.002_bib28","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.jaip.2018.01.035","article-title":"Use of ICS\/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma","volume":"6","author":"Su","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2022.04.002_bib29","first-page":"57","article-title":"Beta2-adrenoceptors: mechanisms of action of beta2-agonists","volume":"2","author":"Johnson","year":"2001","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.iac.2022.04.002_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/ecp.13.2","article-title":"The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations","volume":"6","author":"Louie","year":"2013","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.iac.2022.04.002_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/08923973.2016.1173057","article-title":"Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels","volume":"38","author":"Yalcin","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856122000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856122000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:45:58Z","timestamp":1760179558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856122000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0889856122000248"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2022.04.002","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asthma-Chronic Obstructive Pulmonary Disease Overlap","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2022.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}